Exploring the severity and causes of a debilitating heart condition
Approximately 3 million people in the United States are living with heart failure with preserved ejection fraction, or HFpEF, and their prognosis can be daunting.
Study linking environmental factors and Alzheimer’s disease awarded NIH funding
A nationwide study led by the University of Wisconsin School of Medicine and Public Health that explores the relationship between Alzheimer’s disease, environmental factors and lifetime experiences has been awarded a second round of funding from the National Institutes of Health (NIH).
Fourteen Vilas Awards recognize faculty excellence
Fourteen faculty members in the University of Wisconsin School of Medicine and Public Health received Vilas Awards for the 2025–2026 academic year, the most the school has earned in a single year for at least a decade.
Predicting how residents will perform in the field
Dr. Brigitte Smith received a $1.1 million precision education grant from AMA to build a platform that will help vascular surgery training programs analyze residents’ and recent graduates' performance data.
A comprehensive approach to dementia
No cure exists — yet — for Alzheimer’s disease, the brain disorder that slowly destroys memory and thinking skills, along with the ability to complete daily tasks. But dozens of researchers at the University of Wisconsin–Madison, many of them within the UW School of Medicine and Public Health, are working on ways to prevent, slow and cure the disease.
Overriding a genetic mutation to restore sight
A University of Wisconsin–Madison research team has shown that an engineered molecule can override a genetic error that causes a rare but devastating form of inherited childhood blindness, restoring the missing protein and recovering visual function in patient-derived cells and in a mouse model of the disease.
Remembering Charles Mistretta, medical imaging pioneer
Charles “Chuck” Mistretta, PhD, a pioneering researcher who transformed the field of medical imaging, passed away on June 9, 2026.
UW–Madison researchers identify therapeutic target for dangerous fungal infections
A multidisciplinary team of researchers at UW–Madison has identified a promising new therapeutic candidate against Candida auris, an emerging fungal pathogen able to resist multiple antifungal drugs and spread rapidly through hospitals and care facilities.
New research tracks tick distribution and rising disease risk across Wisconsin
While most people dread finding a tick stuck to their clothing or skin, Johnny Uelmen is literally beating the bushes for them.
UW spinoff company launches clinical trial for metastatic cancer treatment
The first patient in a clinical trial led by Archeus Technologies has received a dose of an investigational therapy to treat metastatic cancer, developed by the clinical-stage company which has ties to the University of Wisconsin–Madison, UW Health’s Isthmus Project and the Wisconsin Alumni Research Foundation.
Research agreement signed with Accuray to improve personalized cancer care
A new 10‑year strategic collaboration between the University of Wisconsin School of Medicine and Public Health and Accuray Incorporated will support clinical research, education and training, and development of adaptive therapies that help empower medical care teams to continually raise the standard in cancer care.
Anjon Audhya assumes inaugural role of vice dean for research
Anjon Audhya, PhD, will become the inaugural vice dean for research for the University of Wisconsin School of Medicine and Public Health effective April 19. The role serves as the chief research officer for the school, charged with articulating the goals and vision of the school’s research enterprise to major stakeholder groups and planning for the long-term success and global impact of research activities.